Suppr超能文献

支气管扩张症急性加重:病因、危险因素、管理及预防的叙述性综述

Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention.

作者信息

Choi Hayoung, Chalmers James D

机构信息

Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.

出版信息

Ann Transl Med. 2023 Jan 15;11(1):25. doi: 10.21037/atm-22-3437. Epub 2022 Nov 16.

Abstract

BACKGROUND AND OBJECTIVE

Bronchiectasis exacerbations are significant events in the natural course of the disease and determine long-term clinical outcomes. This review aims to discuss the definition, causes, risk factors, management and prevention of bronchiectasis exacerbations.

METHODS

The PubMed database was searched for relevant articles published in English between January 1990 and March 2022 using keywords "bronchiectasis" and "exacerbation".

KEY CONTENT AND FINDINGS

Causes of bronchiectasis exacerbation are multifactorial; it can be associated with bacterial and viral pathogens, host inflammatory responses, and external environmental effects. In addition, recent advances in bronchiectasis research highlight the phenotype of patients who are more prone to exacerbations, including those with chronic infection, worse symptoms, greater lung inflammation and comorbid airway diseases. Once bronchiectasis exacerbations occur, antibiotics are the mainstay treatment. Preventing exacerbations is of paramount importance because frequent exacerbations are linked to a detrimental disease course and higher mortality. To prevent frequent exacerbations, clinicians should attempt to understand the risk factors for exacerbation that are amenable to therapeutic intervention: so called "treatable traits". Treatments are personalised but include improving mucociliary clearance by physiotherapy and mucoactive therapy, reducing airway infection by inhaled antibiotics, and inflammation by long-term macrolide or in specific subpopulations, inhaled corticosteroids (ICS). Novel approaches to prevent exacerbations including direct anti-inflammatory therapies are in development for bronchiectasis.

CONCLUSIONS

Future research is needed to better manage and prevent exacerbations in patients with bronchiectasis, although recent studies have characterised frequent exacerbator phenotype and enhanced our understanding of various aspects of exacerbations.

摘要

背景与目的

支气管扩张症急性加重是该疾病自然病程中的重要事件,并决定长期临床结局。本综述旨在探讨支气管扩张症急性加重的定义、病因、危险因素、管理及预防。

方法

在PubMed数据库中检索1990年1月至2022年3月期间发表的英文相关文章,使用关键词“支气管扩张症”和“急性加重”。

关键内容与发现

支气管扩张症急性加重的病因是多因素的;它可能与细菌和病毒病原体、宿主炎症反应及外部环境影响有关。此外,支气管扩张症研究的最新进展突出了更易发生急性加重的患者表型,包括那些有慢性感染、症状更严重、肺部炎症更明显及合并气道疾病的患者。一旦发生支气管扩张症急性加重,抗生素是主要治疗方法。预防急性加重至关重要,因为频繁急性加重与不良疾病进程及更高死亡率相关。为预防频繁急性加重,临床医生应试图了解适合进行治疗干预的急性加重危险因素:即所谓的“可治疗特征”。治疗是个性化的,但包括通过物理治疗和黏液促排剂改善黏液纤毛清除功能、通过吸入抗生素减少气道感染以及通过长期使用大环内酯类药物或在特定亚组中使用吸入性糖皮质激素(ICS)减轻炎症。预防急性加重的新方法包括直接抗炎疗法正在针对支气管扩张症进行研发。

结论

尽管最近的研究已明确频繁急性加重者的表型并增强了我们对急性加重各方面的理解,但仍需要未来的研究以更好地管理和预防支气管扩张症患者的急性加重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7099/9906191/16d3344f15f8/atm-11-01-25-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验